Astrid Kok

2.1k citations

22 papers · 1.7k indexed · h-index 17

Co-authors: Philip Scheltens Marinus A. Blankenstein Wiesje M. van der Flier Femke H. Bouwman Evert J. van Elk Nicolaas A. Verwey Cees Mulder Niki S.M. Schoonenboom
Topics: Dementia and Cognitive Impairment Research (9 papers)Alzheimer's disease research and treatments (8 papers)Neurological Disease Mechanisms and Treatments (4 papers)
Cited by: Psychiatry and Mental health Neurology Physiology
Journals: Neurology Diabetes Care Stroke
Partner nations: Netherlands United States France

In The Last Decade

Astrid Kok

22 papers receiving 1.6k citations

Peers

Countries citing papers authored by Astrid Kok

Since Specialization

Citations

This map shows the geographic impact of Astrid Kok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Kok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Kok more than expected).

Fields of papers citing papers by Astrid Kok

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid Kok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Kok. The network helps show where Astrid Kok may publish in the future.

Co-authorship network of co-authors of Astrid Kok

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Kok. A scholar is included among the top collaborators of Astrid Kok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Kok. Astrid Kok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment and Outcome of Patients with Uterine Carcinosarcoma in a Comprehensive Cancer Network 2019 ·Indian Journal of Gynecologic Oncology ·(unknown),(unknown),(unknown),A.A.M. van der Wurff,M. van ‘t Veer,Dorry Boll,M. Caroline Vos,Brenda Pijlman,Astrid Kok,Jurgen M.J. Piek	3
2	Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients 2014 ·Mucosal Immunology ·Astrid Kok,Laurent Hocqueloux,Hakim Hocini,Marie Carrière,(unknown),Aurélie Guguin,Pascaline Tisserand,Henri Bonnabau,Véronique Avettand-Fènoël,Thiérry Prazuck,Sandrine Katsahian,Philippe Gaulard,Rodolphe Thiébaut,Yves Lévy,Sophie Hüe	62
3	HIV "Elite Controllers" Are Characterized by a High Frequency of Memory CD8+CD73+ T Cells Involved in the Antigen-Specific CD8+ T-cell Response 2013 ·The Journal of Infectious Diseases ·Marie Carrière,Christine Lacabaratz,Astrid Kok,Clarisse Benne,Mohammad-Ali Jenabian,Nicoletta Casartelli,Sophie Hüe,Laurent Hocqueloux,Jean‐Daniel Lelièvre,Yves Lévy	31
4	New Research Criteria for the Diagnosis of Alzheimer’s Disease Applied in a Memory Clinic Population 2010 ·Dementia and Geriatric Cognitive Disorders ·Femke H. Bouwman,Nicolaas A. Verwey,Martin Klein,Astrid Kok,Marinus A. Blankenstein,Jasper D. Sluimer,Frederik Barkhof,Wiesje M. van der Flier,Philip Scheltens	36
5	Amyloid-β(1–42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease 2009 ·Clinical Chemistry ·Cees Mulder,Nicolaas A. Verwey,Wiesje M. van der Flier,Femke H. Bouwman,Astrid Kok,Evert J. van Elk,Philip Scheltens,Marinus A. Blankenstein	279
6	CSF biomarker levels in early and late onset Alzheimer's disease 2008 ·Neurobiology of Aging ·Femke H. Bouwman,Niki S.M. Schoonenboom,Nicolaas A. Verwey,Evert J. van Elk,Astrid Kok,Marinus A. Blankenstein,Philip Scheltens,Wiesje M. van der Flier	114
7	Comparison of two consecutive fat-rich and carbohydrate-rich meals on postprandial myeloperoxidase response in women with and without type 2 diabetes mellitus 2008 ·Metabolism ·Roger K. Schindhelm,Marjan Alssema,Michaëla Diamant,Tom Teerlink,Joost Dekker,Astrid Kok,Piet J. Kostense,Giel Nijpels,Robert J. Heine,P Scheffer	11
8	P1‐371: New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population 2008 ·Alzheimer s & Dementia ·Femke H. Bouwman,Nicolaas A. Verwey,Martin Klein,Yolande A.L. Pijnenburg,Astrid Kok,Marinus A. Blankenstein,Jasper D. Sluimer,Frederik Barkhof,Wiesje M. van der Flier,Philip Scheltens	2
9	Cognitive Impairment in Alzheimer’s Disease Is Modified by APOE Genotype 2007 ·Dementia and Geriatric Cognitive Disorders ·Annelies E. van der Vlies,Yolande A.L. Pijnenburg,Teddy Koene,Martin Klein,Astrid Kok,Philip Scheltens,Wiesje M. van der Flier	59
10	Longitudinal changes of CSF biomarkers in memory clinic patients 2007 ·Neurology ·Femke H. Bouwman,Wiesje M. van der Flier,Niki S.M. Schoonenboom,Evert J. van Elk,Astrid Kok,Frank Rijmen,Marinus A. Blankenstein,Philip Scheltens	100
11	Contribution of Metabolic Syndrome Components to Cognition in Older Individuals 2007 ·Diabetes Care ·Miranda G. Dik,Cees Jonker,Hannie C. Comijs,D.J.H. Deeg,Astrid Kok,Kristine Yaffe,Brenda W.J.H. Penninx	206
12	Stability of Soluble Adhesion Molecules, Selectins, and C-Reactive Protein at Various Temperatures: Implications for Epidemiological and Large-Scale Clinical Studies 2007 ·Clinical Chemistry ·(unknown),Michael M. Gunter,Rafael Perera,Andrew Farmer,C A Cull,Casper G. Schalkwijk,Astrid Kok,Harry Twaalfhoven,Rury R. Holman,Andrew Neil	25
13	Apolipoprotein E Genotype Influences Presence and Severity of Delusions and Aggressive Behavior in Alzheimer Disease 2006 ·Dementia and Geriatric Cognitive Disorders ·Wiesje M. van der Flier,Salka S. Staekenborg,Yolande A.L. Pijnenburg,Freek Gillissen,(unknown),Astrid Kok,Femke H. Bouwman,Philip Scheltens	44
14	CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment 2006 ·Neurobiology of Aging ·Femke H. Bouwman,S.N.M. Schoonenboom,Wiesje M. van der Flier,Evert J. van Elk,Astrid Kok,Frederik Barkhof,Marinus A. Blankenstein,Philip Scheltens	139
15	P3–137: The metabolic syndrome, inflammation, and cognitive decline 2006 ·Alzheimer s & Dementia ·Miranda G. Dik,Brenda W.J.H. Penninx,Hannie C. Comijs,Dorly J. H. Deeg,Astrid Kok,Kristine Yaffe,Cees Jonker	2
16	Stroke and Apolipoprotein E ε4 Are Independent Risk Factors for Cognitive Decline 2000 ·Stroke ·Miranda G. Dik,Dorly J. H. Deeg,L.M. Bouter,Elizabeth H. Corder,Astrid Kok,C. Jonker	71
17	Plasma concentration of C-reactive protein is increased in Type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation 1999 ·Diabetologia ·Casper G. Schalkwijk,Dennis C.W. Poland,W. van Dijk,Astrid Kok,J.J. Emeis,(unknown),Andrea Doni,Victor W.M. van Hinsbergh,Coen D.A. Stehouwer	261
18	An Enzyme-Linked Immunosorbent Assay for the Measurement of Circulating Antibodies to Polymorphic Epithelial Mucin (MUC1) 1998 ·Tumor Biology ·Silvia von Mensdorff‐Pouilly,(unknown),Peter Kenemans,(unknown),Gerard J. van Kamp,Astrid Kok,(unknown),Frank G.M. Snijdewint,Marinus A. Paul,Sybren L. Meijer,J. Hilgers	57
19	Helicobacter pylori, pepsinogens and gastrin 1996 ·European Journal of Gastroenterology & Hepatology ·Ernst J. Kuipers,Gerard Pals,A. S. Peña,(unknown),Astrid Kok,B. D. Westerveld,S. G. M. Meuwissen	19
20	Evaluation of colorectal cancer-associated mucin CA M43 assay in serum 1993 ·Clinical Chemistry ·Gerard J. van Kamp,Silvia von Mensdorff‐Pouilly,Peter Kenemans,Rob A. Verstraeten,(unknown),Theo Wobbes,(unknown),Astrid Kok,Joseph P. Brown,J. Hilgers	6

About Astrid Kok

Astrid Kok is a scholar working on Psychiatry and Mental health, Neurology and Virology, having authored 22 papers that have together received 1.7k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (9 papers), Alzheimer's disease research and treatments (8 papers) and Neurological Disease Mechanisms and Treatments (4 papers). The work is most often cited by research in Psychiatry and Mental health (710 citations), Neurology (245 citations) and Physiology (748 citations). Astrid Kok has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Philip Scheltens, Marinus A. Blankenstein, Wiesje M. van der Flier, Femke H. Bouwman, Evert J. van Elk, Nicolaas A. Verwey, Cees Mulder, Niki S.M. Schoonenboom, Miranda G. Dik and Casper G. Schalkwijk. Their work appears in journals such as Neurology, Diabetes Care and Stroke.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact